Raymond James analyst Jason Bedford raised the firm’s price target on Intuitive Surgical to $323 from $270 and keeps an Outperform rating on the shares. Intuitive Surgical delivered a "stellar" Q1, highlighting a procedure recovery story, and Raymond James tells investors in a research note that "it is hard not to" come away from the Q1 results with a more positive view.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ISRG:
